- Gallium chloride
Manufacture of electronic instruments, semiconductors, alloys, and lubricants, used to treat lung cancer.
Registry Numbers and Inventories.
Melting point, °C
Boiling point, °C
Vapor pressure, mmHg
10.4 (78 C)
2.29 g/cm3 (80 C)
Solubility in water
Heat of fusion
Hazards and Protection.
Keep in a cool, dry, dark location in a tightly sealed container or cylinder. Keep away from incompatible materials, ignition sources and untrained individuals. Secure and label area. Protect containers/cylinders from physical damage.
All chemicals should be considered hazardous. Avoid direct physical contact. Use appropriate, approved safety equipment. Untrained individuals should not handle this chemical or its container. Handling should occur in a chemical fume hood.
Chemical splash goggles in compliance with OSHA regulations are advised; however, OSHA regulations also permit other type safety glasses. Whre chemical resistant gloves. To prevent repeated or prolonged skin contact, wear impervious clothing and boots.
Use NIOSH/MSHA approved respirator appropriate for exposure of concern.
Avoid inhalation and skin contact.
Strong oxidizing agents.
Wear a self-contained breathing apparatus in pressure-demand, MSHA/NIOSH (approved or equivalent), and full protective gear. During a fire, irritating and highly toxic gases may be generated by thermal decomposition or combustion. Use agent most appropriate to extinguish fire.
Emits toxic chloride fumes when heated to decomposition. Decomposes upon sufficient heating.
Peripheral neuropathy has been observed in a single patient with exposure to the similar compound, gallium trifluoride.
Anorexia, nausea, and vomiting might occur.
Respiratory tract irritation - chlorine vapors released from gallium trichloride can cause wheezing, coughing, dyspnea, a sense of suffocation, burning chest pain, and, in more severe cases, cyanosis, laryngeal edema, respiratory arrest, or delayed pulmonary edema.
Seek medical attention. If individual is drowsy or unconscious, do not give anything by mouth; place individual on the left side with the head down. Contact a physician, medical facility, or poison control center for advice about whether to induce vomiting. If possible, do not leave individual unattended.
Move patient to fresh air. Monitor for respiratory distress. If cough or difficulty breathing develops, evaluate for respiratory tract irritation, bronchitis, or pneumonitis. Administer oxygen and assist ventilation as required. Treat bronchospasm with beta2 agonist and corticosteroid aerosols.
Remove contaminated clothing and wash exposed area thoroughly with soap and water. A physician should examine the area if irritation or pain persists.
Irrigate exposed eyes with copious amounts of tepid water for at least 15 minutes. If irritation, pain, swelling, lacrimation, or photophobia persist, the patient should be seen in a health care facility.
USCG CHRIS Code